BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38074816)

  • 21. System analysis of
    Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
    Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elucidating cuproptosis-related gene SLC31A1 diagnostic and prognostic values in cancer.
    Mi J; Luo J; Zeng H; Zhang H; Jamil M; Abdel-Maksoud MA; Zakri AM; Alfuraydi AA; Zhang N; Xiao M
    Am J Transl Res; 2023; 15(10):6026-6041. PubMed ID: 37969191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activating mutations in PTPN3 promote cholangiocarcinoma cell proliferation and migration and are associated with tumor recurrence in patients.
    Gao Q; Zhao YJ; Wang XY; Guo WJ; Gao S; Wei L; Shi JY; Shi GM; Wang ZC; Zhang YN; Shi YH; Ding J; Ding ZB; Ke AW; Dai Z; Wu FZ; Wang H; Qiu ZP; Chen ZA; Zhang ZF; Qiu SJ; Zhou J; He XH; Fan J
    Gastroenterology; 2014 May; 146(5):1397-407. PubMed ID: 24503127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
    Guo L; Li X; Liu R; Chen Y; Ren C; Du S
    Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches.
    Jiang J; Zhang Y; Wang J; Yang X; Ren X; Huang H; Wang J; Lu J; Zhong Y; Lin Z; Lin X; Jia Y; Lin S
    PeerJ; 2023; 11():e16166. PubMed ID: 37790630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic Landscape of RTK/RAS Pathway and Tumor Immune Infiltration as Prognostic Indicator of Lung Adenocarcinoma.
    Yin XQ; Yin XH; Yu YQ; Xu L; Zhang M
    Front Oncol; 2022; 12():924239. PubMed ID: 35936718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of the protein tyrosine phosphatase PTPN3 with viral and cellular partners through its PDZ domain: insights into structural determinants and phosphatase activity.
    Genera M; Colcombet-Cazenave B; Croitoru A; Raynal B; Mechaly A; Caillet J; Haouz A; Wolff N; Caillet-Saguy C
    Front Mol Biosci; 2023; 10():1192621. PubMed ID: 37200868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates.
    Wei Q; Miao T; Zhang P; Jiang B; Yan H
    Front Genet; 2022; 13():984575. PubMed ID: 36159963
    [No Abstract]   [Full Text] [Related]  

  • 29. PTPN3 and PTPN4 tyrosine phosphatase expression in human gastric adenocarcinoma.
    Wu CW; Chen JH; Kao HL; Li AF; Lai CH; Chi CW; Lin WC
    Anticancer Res; 2006; 26(2B):1643-9. PubMed ID: 16619586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Expression of PTPN3 Predicts Progression and Unfavorable Prognosis of Glioblastoma.
    Wang Y; Su Y; Ji Z; Lv Z
    Med Sci Monit; 2018 Oct; 24():7556-7562. PubMed ID: 30348936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PTPN3 suppresses the proliferation and correlates with favorable prognosis of perihilar cholangiocarcinoma by inhibiting AKT phosphorylation.
    Sun R; Chen T; Li M; Liu Z; Qiu B; Li Z; Xu Y; Pan C; Zhang Z
    Biomed Pharmacother; 2020 Jan; 121():109583. PubMed ID: 31706106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comprehensive Analysis of the Relationship between m6A Methylation Patterns and Immune Microenvironment in Lung Adenocarcinoma].
    Ke J; Cui J; Yang X; Du X; Ma B; Yu L
    Zhongguo Fei Ai Za Zhi; 2022 May; 25(5):311-322. PubMed ID: 35599007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma.
    Cao K; Ling X; Jiang X; Ma J; Zhu J
    Respir Res; 2022 Nov; 23(1):306. PubMed ID: 36357897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. m7G-Associated subtypes, tumor microenvironment, and validation of prognostic signature in lung adenocarcinoma.
    Wang G; Zhao M; Li J; Li G; Zheng F; Xu G; Hong X
    Front Genet; 2022; 13():954840. PubMed ID: 36046251
    [No Abstract]   [Full Text] [Related]  

  • 35. Integration of multiple key molecules in lung adenocarcinoma identifies prognostic and immunotherapeutic relevant gene signatures.
    Wu Q; Wang L; Wei H; Li B; Yang J; Wang Z; Xu J; Zhou YL; Zhang B
    Int Immunopharmacol; 2020 Jun; 83():106477. PubMed ID: 32278127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
    Ma C; Kang W; Yu L; Yang Z; Ding T
    Front Oncol; 2020; 10():590006. PubMed ID: 33363020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA WAC-AS1 expression in human tumors correlates with immune infiltration and affects prognosis.
    Wang Y; Gong H; Cao Y
    Hereditas; 2023 May; 160(1):26. PubMed ID: 37248547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of hepatitis B viral gene expression by protein-tyrosine phosphatase PTPN3.
    Hsu EC; Lin YC; Hung CS; Huang CJ; Lee MY; Yang SC; Ting LP
    J Biomed Sci; 2007 Nov; 14(6):731-44. PubMed ID: 17588219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive analysis of resistance mechanisms to EGFR-TKIs and establishment and validation of prognostic model.
    Yang Z; Li H; Dong T; Li G; Chen D; Li S; Wang Y; Pan Y; Lu T; Yang G; Zhang G; Cheng P; Wang X
    J Cancer Res Clin Oncol; 2023 Nov; 149(15):13773-13792. PubMed ID: 37532906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.